Point72 Asia (Singapore) Pte. Ltd. Rezolute, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Rezolute, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 19,799 shares of RZLT stock, worth $60,386. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,799
Previous 13,329
48.54%
Holding current value
$60,386
Previous $64.6 Million
50.07%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
76Shares Held
44.6MCall Options Held
201KPut Options Held
2.8K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$34.4 Million0.13% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.86MShares$8.72 Million0.69% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$8.53 Million2.6% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$7.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$7.08 Million0.0% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $118M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...